Skip to Main Content

Paper Details

Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial.
Intensive Care Med
13
2020
Author NameAffiliation
Anthony C GordonImperial College Healthcare NHS Trust
Anthony C GordonImperial College London
  • 1 - 2

Datasets

Release 1.2